Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

methyl bacteriopurpurinimide

A brain-penetrant bacteriochlorin analog and photosensitizer, with potential imaging and antineoplastic activities upon fluorescence imaging and fluorescence-guided photodynamic therapy (PDT) respectively. Upon administration, methyl bacteriopurpurinimide crosses the blood brain barrier (BBB) and is taken up by tumor cells. Upon clinical near-infrared (NIR) imaging, the tumor cells can be detected which allows for visualization of the tumor. Upon NIR PDT, the tumor cells are killed.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Photobac
Chemical structure:3-(1-butyloxy)ethyl-3-deacetyl-bacteriopurpurin-18-n-butylimide methyl ester
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search